SCHEMBL27579947

SCHEMBL27579947

CS(=O)(=O)c1ccc([C@H](CC(=O)Nc2ccc(Cl)cn2)C2CCC(=NO)CC2)cc1Cl

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ GCK P35557 3/20 0.43
▸ KCNH2 Q12809 2/20 0.42
▸ HTT P42858 1/20 0.42
▸ NPSR1 Q6W5P4 1/20 0.42
▸ TDP1 Q9NUW8 1/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ MAPT P10636 2/20 0.38
▸ L3MBTL1 Q9Y468 3/20 0.38
▸ RAB9A P51151 4/20 0.37
▸ NPC1 O15118 3/20 0.37
▸ MAPK1 P28482 2/20 0.37
▸ HPGD P15428 2/20 0.37
▸ TP53 P04637 1/20 0.37
▸ PKM P14618 1/20 0.37
▸ TSHR P16473 1/20 0.37
▸ GLA P06280 1/20 0.37
▸ POLB P06746 2/20 0.37
▸ THRB P10828 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28747106 0.93 GCK (0.43) GCKKCNH2HTTNPSR1SMN1; SMN2
SCHEMBL2642140 0.91 GCK (0.48) GCKKCNH2HTTNPSR1TDP1
SCHEMBL27557991 0.91 KCNH2 (0.45) GCKKCNH2HTTNPSR1
SCHEMBL27557961 0.91 KCNH2 (0.45) GCKKCNH2HTTNPSR1SMN1; SMN2
SCHEMBL2642234 0.84 GCK (0.47) GCKKCNH2HTTSMN1; SMN2RAB9A
SCHEMBL2642093 0.81 KCNH2 (0.63) GCKKCNH2L3MBTL1MAPK1TSHR
SCHEMBL2642090 0.81 KCNH2 (0.63) GCKKCNH2L3MBTL1MAPK1TSHR
SCHEMBL27578456 0.81 GCK (0.50) GCKKCNH2HTTNPSR1
SCHEMBL2653752 0.81 GCK (0.50) GCKKCNH2HTTNPSR1SMN1; SMN2
SCHEMBL2642192 0.81 GCK (0.50) GCKKCNH2HTTNPSR1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1329386-C Substituted phenylacetamides and their use as glucokinase activators HOFFMANN LA ROCHE CO LTD (CH) 2007-08-01 — — CN claimed
CN-1649859-A Substituted phenylacetamides and their use as glucokinase activators HOFFMANN LA ROCHE (CH) 2005-08-03 — — CN claimed
CN-1329386-C Substituted phenylacetamides and their use as glucokinase activators HOFFMANN LA ROCHE CO LTD (CH) 2007-08-01 — — CN disclosed
CN-1649859-A Substituted phenylacetamides and their use as glucokinase activators HOFFMANN LA ROCHE (CH) 2005-08-03 — — CN disclosed
Send feedback